Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
| Status: | Completed |
|---|---|
| Conditions: | Liver Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | April 2006 |
| End Date: | January 2015 |
Phase I Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
This trial is testing the safety of combining the oral chemotherapy drug capecitabine with
radio-labeled microspheres injected directly into the liver.
radio-labeled microspheres injected directly into the liver.
Patients with adequate liver function and performance status in whom liver-directed therapy
and capecitabine would be appropriate are eligible for this clinical trial.
and capecitabine would be appropriate are eligible for this clinical trial.
Inclusion Criteria:
- Adequate liver function
- Adequate performance status
Exclusion Criteria:
- Significant extrahepatic disease
We found this trial at
1
site
Click here to add this to my saved trials
